Dr Ed Wild with Jenni Murray and HD family member Susan Fletcher, talk about Huntington’s disease on Woman’s Hour. Broadcast 15th July 2016.

Dr Ed Wild of UCL Huntington’s Disease Centre (Institute of Neurology) delivers an update on Ionis Pharmaceuticals 443139-CS1 trial, testing HTTRx, a huntingtin-lowering antisense oligonucleotide or ‘gene silencing’ drug in Huntington’s disease patients.

Dr Ed Wild and Dr Jeff Carroll present a live recording of their 2016 research update at the 2016 Huntington’s Disease Society of America Convention in Baltimore, entitled “The Best Time to Plant a Tree”, including updates on the Teva Pride-HD and Legato studies, Pfizer’s Amaryllis study, and Ionis Pharmaceuticals’ HTTRx ‘gene silencing’ trial.

Biomarkers and Biological Insights from Huntington's Disease Patient Cerebrospinal Fluid from Gene Veritas on Vimeo.

Ed Wild talks at the 2015 CHDI Huntington’s Disease Therapeutics Conference in Palm Springs. Video by Ken Serbin / Gene Veritas.